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To the Editor, 
Chronic Granulomatous Disease (CGD) is a rare primary immunodeficiency caused 
by defects in NADPH oxidase complex, of which around 80% of cases in the UK are 
X-linked (XL) [1]. Female carriers of XL-CGD have a dual population of phagocytes. 
It is recognised that they experience a range of infective, inflammatory, and 
autoimmune complications of CGD [2]. Many XL-CGD carriers also report excessive 
fatigue [2]. 
Fatigue has been reported as a significant symptom in chronic inflammatory and 
autoimmune conditions including systemic lupus erythematosus, rheumatoid arthritis, 
inflammatory bowel disease, sarcoidosis and Sjögren’s syndrome. In these 
conditions, patients report fatigue as one of the most important and troubling 
symptoms which impacts significantly upon quality of life [3]. The presence of fatigue 
in inflammatory conditions and the association with ongoing inflammation suggests 
an inflammatory mechanism. Evidence of pro-inflammatory cytokine involvement in 
fatigue has been reported in both animal and human models [3].  
Serum samples were collected during a study of the healthy female XL-CGD carriers 
from the UK, identified through a UK CGD Registry. Symptoms of excessive fatigue 
were investigated using the Multidimensional Fatigue Symptom Inventory Short 
Form (MFSI-SF). Stored serum from 52 subjects was measured for serum levels of 
pro-inflammatory cytokines (IL-1α, IL-5, IL-8, IL-10, IL-17, TGFβ1, IFNα and IFN-γ) 
by Cytometric Bead Array (CBA) immunoassay using a BD Biosciences LSR 
Fortessa X-20™ cell analyser (Becton Dickinson, Oxford, UK). 
Results were compared with inflammatory disease control groups of 10 high and 10 
low fatigue Sjögren's syndrome patients and 15 healthy controls. All controls were 
matched for sex and age. XL-CGD carriers were divided into two groups; those who 
reported fatigue and those who did not. Median age of XL-CGD carriers was 41.5 
years (8.5-65.9), ethnicity 96% White British. Statistical analysis was undertaken 
between the groups using STATA and medians were compared using a Mann-
Whitney U test for non-parametric data. A p value ≤0.05 was considered statistically 
significant. 
Forty-eight percent (25/52) of XL-CGD carriers reported suffering excessive fatigue, 
associated with significantly higher scores in the MFSISF (p<0.01). There were no 
differences between those with relatives with CGD who had or had not been 
transplanted, controlling for fatigue associated with the psychological stress of 
having a relative with a serious disease. 
Interleukin (IL)-8 levels were significantly higher in XL-CGD carriers (mean 
1459u/ml) than in healthy controls (mean 72u/ml) (p=0.015) and patients with 
Sjögren’s syndrome (mean 203u/ml) (p=0.031) (Figure 1). IL-8 levels were also 
significantly higher in the group of XL-CGD carriers who reported high levels of 
fatigue (mean 2405u/ml) than in those not reporting fatigue (400u/ml) (p=0.017). 
No other cytokines reached statistically significant different levels between groups. 
Many XL-CGD carriers reported high levels of fatigue. The significantly higher serum 
IL-8 levels in XL-CGD carriers than healthy and Sjögren’s syndrome controls and the 
significantly higher levels in those reporting fatigue suggests a biological explanation 
for the symptoms, particularly as there were no differences in fatigue within families 
who had transplanted or non-transplanted index cases. 
Previous studies have associated raised IL-8 with excessive fatigue [4], however this 
is the first study to evaluate fatigue and pro-inflammatory cytokines in XL-CGD 
carriers. 
Although the serum samples were obtained at different time periods, they were 
collected at the same time as data about fatigue levels. Despite the limitations of the 
study, this is an important finding and demonstrates for the first time that many XL-
CGD carriers, previously thought to be unaffected, experience significant fatigue for 
which there may be a biological cause. Previous studies have shown that gene 
expression of pro-inflammatory cytokines is up-regulated in neutrophils from XL-
CGD patients, including IL-8 [5]. Whilst similar observations have not been 
demonstrated in XL-CGD carriers, it is likely that the phagocyte population 
expressing the mutated X-chromosome would show similar findings. Further 
research is required to evaluate this finding in XL-CGD carriers. Importantly, the 
finding of a potential biological explanation for the symptoms of fatigue opens up the 
possibility of therapeutic intervention for this population. 
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Figure 1 - Log box plot of IL-8 concentration in each study group 
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